Back to Search Start Over

Tumor-derived IL-6 may contribute to the immunological defect in CLL.

Authors :
Buggins, A. G. S.
Patten, P. E. M.
Richards, J.
Thomas, N. S. B.
Mufti, G. J.
Devereux, S.
Source :
Leukemia (08876924); May2008, Vol. 22 Issue 5, p1084-1087, 4p, 4 Graphs
Publication Year :
2008

Abstract

A letter to the editor is presented in response to the article related to the contribution of tumor-derived interleukin-6 (IL-6) to the immunological defect of chronic lymphocytic leukemia (CLL) in the November 1, 2007 issue.

Subjects

Subjects :
LETTERS to the editor
INTERLEUKIN-6

Details

Language :
English
ISSN :
08876924
Volume :
22
Issue :
5
Database :
Complementary Index
Journal :
Leukemia (08876924)
Publication Type :
Academic Journal
Accession number :
32004631
Full Text :
https://doi.org/10.1038/sj.leu.2405015
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details